Global Active Pharma Ingredient Market is classified on the basis oftype, type of manufacturer, type of synthesis, type of drug, therapeutic application and geography. A substance or blend of substances used in a finished pharmaceutical product (FPP) in order to provide pharmacological activity is known as an active pharma ingredient. They have a direct effect in the treatment, diagnosis or mitigation of the disease.The factors that propel the growth of the global market include increasing demand, growing occurrence of cancer, technological innovations, rapid industrialization, rise in number of chronic diseases, rising uptake of biopharmaceuticals and growing geriatric population. On the other hand, there are also factors that may hamper the growth of the market such ashigh production cost and strict rules & regulations.
Active Pharmaceutical Ingredient Market is classified on the basis oftype asinnovative APIs and generic APIS. Active Pharma Ingredient Market is classified on the basis oftype of manufacturer as captive manufacturers and merchant manufacturers. The merchant manufacturers are further classified on the basis of type and type of synthesis. Based on type, merchant manufacturers are classified as innovative merchant API manufacturers and generic merchant API manufacturers. Based on type of synthesis, merchant manufacturers are classified as synthetic APIs and biotech APIs. Active Pharma Ingredient Market is classified on the basis oftype of synthesisas synthetic and biotech.
Based on type, the synthetic segment is further classified as innovative synthetic APIs and generic synthetic APIs. The biotech segment is further classified on the basis of type, product, and expression system. Based on type, the biotech segment is classified as innovative biotech APIs and biosimilars. Based on product, the biotech segment is classified as blood factors, cytokines, fusion proteins, hormones, monoclonal antibodies, therapeutic enzymes and vaccines. Based on expression system, the biotech segment is further classified as microbial expression systems, insect expression systems, mammalian expression systems, plant expression systems, yeast expression systems and others.
Active Pharmaceutical Ingredient Market is classified on the basis oftype of drug as prescription drugs and over-the-counter drugs. Active Pharma Ingredient Market is classified on the basis of therapeutic applicationas diabetes, cardiovascular disease, CNS and neurological disorders, oncology, endocrinology and others. The other therapeutic applications include pulmonology, orthopaedics, ophthalmology, urology and nephrology, women’s health, and gastroenterology.
Active Pharma Ingredient Market is classified on the basis ofgeography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa. The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia& New Zealand. The Middle East and Africa region consists of GCC, South Africa and North Africa. In case of geographical region, North America is projected to account a significant share of the Global Active Pharmaceutical Ingredient Market. Some of the key players that fuel the growth of the Active Pharma Ingredient Market include AbbVie Inc., BoehringerIngelheim, Bristol-Myers Squibb, Pfizer, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Sanofi, Teva Pharmaceutical Industries Ltd., and others.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Active Pharma Ingredient in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Active Pharma Ingredient market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Johnson & Johnson
• North China Pharmaceutical Group
• Dr. Reddy's Laboratories
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Zhejiang Medicine
• Johnson Matthey
• Hisun Pharmacy
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group
• Tian Yao
• North East Pharmaceutical
• Shandong Lukang Pharmaceutical
• Jiangsu Hengrui Medicine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Innovative Active Pharmaceutical Ingredients
• Generic Active Pharmaceutical Ingredients
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Cardiovascular Disease
• Central Nervous System and Neurological Disorders
• Other Therapeutic Applications
Research Support Specialist, USA